Johnson & Johnson to acquire cardiovascular specialist V-Wave for up to $1.7bn
The acquisition is the latest in a string of recent deals by J&J to solidify its cardiovascular market position.
21 August 2024
21 August 2024
The acquisition is the latest in a string of recent deals by J&J to solidify its cardiovascular market position.
The two entities will advance clinical trials for coronary and carotid indications using the Pulse IVL system.
The clearance paves the way for the expansion of the company into the US healthcare market.
The app enables users to track their treatments and understand their migraine patterns.
The registrational study aims to enrol up to 25,000 participants aged 50-80 who will undergo annual MCED testing for three years.
The move is set to enhance Vantedge's position in the surgical stapler market and expand its consumable portfolio offering.
The global market for robotic surgical systems and their accessories will reach $10 billion by the end of 2024 and $15.8 billion by 2030.
Securing early funding for medical device development is hard as only a few sources of dedicated organised capital are available in the space.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.